Library

849 Results

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Why managing variability?

Why managing variability?

SIO/ADM | 02-Oct-2017 | Research Study

Significant efforts are necessary to develop an active pharmaceutical ingredient (API). It is therefore risky to expose this API to poorly characterized...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

How to get reproducible DNA amplification

How to get reproducible DNA amplification

Eppendorf for Bioprocess – Solutions that grow with you | 27-Jun-2017 | Infographic

DNA concentration, mastermix preparation, temperature management: Doing PCR like a pro can be more complex than it seems.The Eppendorf infographic helps...

Increase tablet production with multi-tip tools

Increase tablet production with multi-tip tools

I Holland Limited - Tabletting Science | 01-Jun-2017 | Technical / White Paper

Multi-tip punches increase the number of tablets produced per turret rotation, which increases production rates of existing presses.This tooling has transformed...

REC130

Selecting a dosage form for delivery to the lungs

Recipharm AB | 15-May-2017 | Technical / White Paper

Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required...

First-in-Human Development Strategies

First-in-Human Development Strategies

Catalent Pharma Solutions | 01-May-2017 | Insight Guide

Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate....